Minimum biopsy set for HER2 evaluation in gastric and gastro-esophageal junction cancer

Minimum biopsy set for HER2 evaluation in gastric and gastro-esophageal junction cancer

Background and study aims: The HER2 status of small endoscopic biopsies is important for predicting the eligibility of patients with metastatic HER2-positive gastric cancer or gastro-esophageal junction (GEJ) cancer for anti-HER2 therapy approved by the U.S. Food and Drug Administration. The aim of...

Full description

Bibliographic Details
Main Authors: Gullo, Irene, Grillo, Federica, Molinaro, Luca, Fassan, Matteo, De Silvestri, Annalisa, Tinelli, Carmine, Rugge, Massimo, Fiocca, Roberto, Mastracci, Luca
Format: Online
Language:English
Published: © Georg Thieme Verlag KG 2015
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4477016/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4477016/

Similar Items